Previous Page  6 / 19 Next Page
Information
Show Menu
Previous Page 6 / 19 Next Page
Page Background

Journal of Neurology and Neurorehabilitation Research

|

Volume 3

Page 22

Note:

allied

academies

J u n e 2 8 - 2 9 , 2 0 1 8 | D u b l i n , I r e l a n d

Joint Event on

NEUROSCIENCE AND NEUROLOGICAL DISORDERS

PSYCHIATRY AND PSYCHOLOGICAL DISORDERS

&

International Conference on

International Conference on

EFFECTS OF A UNIQUE SOUND

STIMULATION AUDITORY

TRAINING PROGRAM ON DEPRESSIVE

Amir H Yassari

Northwestern University, Germany

P

atients with psychiatric diseases and depression in particular show

deficits in cognitive (e.g. executive function) as well as social cognitive

abilities (e.g. mentalizing). These deficits lead to interpersonal problems

making it difficult to build relationships, thus reinforcing social seclusionand

accentuating the burden of depressive symptoms. Add-on therapies

supporting standard treatment, such as metacognitive therapy, have shown

their efficacy in improving cognitive and emotional fixations in patients with

depression (PD). Further interventions based on music (e.g. music therapy

and auditory training) have gained an important role in the last decade.

Especiallyauditory training promises to enhance the function of the ear and

brain and by extension a patient’s active listening skills or mindfulness. Yet

no study has systematically investigated the effects of auditory training on

mindfulness and the betterment of symptoms in PD. For the first we have

studied the effect of a unique sound stimulation auditory training program. We

believe that our case study illustrates that auditory training has a significant

effect on mindfulness and by extension on measurable behavioral outcomes

in terms of social cognitive (theory of mind and meta cognitive abilities), and

neurocognitive abilities (attention span, executive function) and consequently

social interactions thus reducing depressive symptoms. With this case study

we present a unique, practical, cost-effective add-on therapy with no adverse

effects that can be effectively and efficiently administered to PD to reduce the

burden of disease.

Amir H Yassari has finished his medical school

in Vienna and has researched at Northwestern

University and UC San Diego. He obtained his

MSc in Cognitive Neuroscience from King’s

College London working on social cognition.

Currently, he is working in the outpatient care,

diagnosing prodromal psychotic patients.

a.yassari@uke.de

BIOGRAPHY

Amir H Yassari, J Neurol Neurorehabil Res 2018, Volume 3